Video

HFA 2019: Updates From the ESC HFA EORP HF Long-Term Registry

Published: 10 Jun 2019

  • Views:

    Views Icon 29
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Dr Chris J Kapelios (Laiko General Hospital, Athens, GR) discusses sacubitril / valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long-term Registry: bridging between the PARADIGM HF trial, ESC Guidelines and the real world.

Questions:

Why did you conduct this analysis?

How did you collect and analyse the data?

What were your findings?

How should this study influence practice and research with Sacubitril/valsartan?

Interviewer: Liam O'Neill

Videographer: Mike Knight

Filmed on site at HFA 2019.